Delayed onset septic pelvic thrombophlebitis treated by tissue-plasminogen activator following initial treatment for massive right ovarian vein thrombosis and methicillin-resistant Staphylococcus aureus bacteremia: A case report.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wiley on behalf of the Japan Society of Obstetrics and Gynecology] Country of Publication: Australia NLM ID: 9612761 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1447-0756 (Electronic) Linking ISSN: 13418076 NLM ISO Abbreviation: J Obstet Gynaecol Res Subsets: MEDLINE
    • Publication Information:
      Publication: [Melbourne, Vic. : Wiley on behalf of the Japan Society of Obstetrics and Gynecology]
      Original Publication: Tokyo : University of Tokyo Press, c1996-
    • Subject Terms:
    • Abstract:
      Septic pelvic thrombophlebitis (SPT) is a rare condition that forms thrombosis in the pelvic veins, typically the ovarian veins, with subsequent infection and inflammation. We present a case of right ovarian vein thrombosis (ROVT), methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, and delayed onset of SPT symptoms, requiring tissue-plasminogen activator. A 40-year-old woman, G3P2, at 38 weeks' gestation, was admitted with a fever of 39°C. She had cervical insufficiency and had been often on bed rest. Blood culture revealed MRSA and computed tomography revealed a large ROVT. She received vancomycin and direct oral anticoagulant, and her fever resolved by day 3. On day 16, fever recurred with severe pain over the ROVT. Second computed tomography showed thickening of venous wall with enhancement around ROVT, consistent with SPT. Since pain and fever gradually exacerbated despite treatment with DOAC and antimicrobials, she was started on heparin and tissue plasminogen activator on days 23 and 25, respectively. Along with recanalization on the thrombosis by day 29, fever and abdominal pain resolved. We experienced a case of delayed onset SPT associated with MRSA bacteremia and a large ROVT. MRSA bacteremia might cause the originally existing ROVT to become an infection source, resulting in SPT with recurrent symptoms and long-term treatment. Early and strict anticoagulation is crucial in cases with a large thrombosis and bacteremia, due to the high risk of progression to SPT. This case highlights the importance of recanalization for the treatment of SPT and usefulness of administration of tissue-plasminogen activator for the massive thrombosis.
      (© 2024 The Author(s). Journal of Obstetrics and Gynaecology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Obstetrics and Gynecology.)
    • References:
      Dotters‐Katz SK, Smid MC, Grace MR, Thompson JL, Heine RP, Manuck T. Risk factors for postpartum septic pelvic thrombophlebitis: a multicenter cohort. Am J Perinatol. 2017;34(11):1148–1151. https://doi.org/10.1055/s-0037-1604245.
      Brown CE, Stettler RW, Twickler D, Cunningham FG. Puerperal septic pelvic thrombophlebitis: incidence and response to heparin therapy. Am J Obstet Gynecol. 1999;181(1):143–148. https://doi.org/10.1016/s0002-9378(99)70450-3.
      Witlin AG, Mercer BM, Sibal BM. Septic pelvic thrombophlebitis or refractory postpartum fever of undetermined etiology. J Matern Fetal Med. 1996;5(6):355–358. https://doi.org/10.1002/(sici)1520-6661(199611/12)5:6<355::Aid-mfm12>3.0.Co;2-g.
      Valerio L, Riva N. Head, neck, and abdominopelvic septic thrombophlebitis: current evidence and challenges in diagnosis and treatment. Hamostaseologie. 2020;40(3):301–310. https://doi.org/10.1055/a-1177-5127.
      Yamamoto S, Okamoto K, Okugawa S, Moriya K. Fusobacterium necrophorum septic pelvic thrombophlebitis after intrauterine device insertion. Int J Gynaecol Obstet. 2019;145(1):122–123. https://doi.org/10.1002/ijgo.12760.
      Parino E, Mulinaris E, Saccomano E, Gallo JC, Kohan G. Postpartum ovarian vein thrombophlebitis with staphylococcal bacteremia. Case Rep Infect Dis. 2015;2015(2015):589436. https://doi.org/10.1155/2015/589436.
      Wilson Dib R, Chaftari AM, Hachem RY, Yuan Y, Dandachi D, Raad II. Catheter‐related Staphylococcus aureus bacteremia and septic thrombosis: the role of anticoagulation therapy and duration of intravenous antibiotic therapy. Open Forum Infect Dis. 2018;5(10):ofy249. https://doi.org/10.1093/ofid/ofy249.
      Khalil H, Avruch L, Olivier A, Walker M, Rodger M. The natural history of pelvic vein thrombosis on magnetic resonance venography after vaginal delivery. Am J Obstet Gynecol. 2012;206(4):356.e1–356.e4. https://doi.org/10.1016/j.ajog.2012.01.006.
      Rodger MA, Avruch LI, Howley HE, Olivier A, Walker MC. Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section. Am J Obstet Gynecol. 2006;194(2):436–437. https://doi.org/10.1016/j.ajog.2005.07.044.
      Van Hoecke F, Lamont B, Van Leemput A, Vervaeke S. A Lemierre‐like syndrome caused by Staphylococcus aureus: an emerging disease. Infect Dis (Lond). 2020;52(3):143–151. https://doi.org/10.1080/23744235.2019.1691255.
      Riva N, Ageno W. Direct oral anticoagulants for unusual‐site venous thromboembolism. Res Pract Thromb Haemost. 2021;5(2):265–277. https://doi.org/10.1002/rth2.12480.
      Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy, The Jaid J. S. C. Guide Guidelines to Clinical Management of Infectious Disease Preparing Committee Sepsis working group, Arakawa S, et al. The JAID/JSC guidelines for management of infectious diseases 2017—sepsis and catheter‐related bloodstream infection. J Infect Chemother. 2021;27(5):657–677. https://doi.org/10.1016/j.jiac.2019.11.011.
      Li W, Cao S, Zhu R, Chen X. Idiopathic ovarian vein thrombosis causing pulmonary embolism: case report and literature review. J Int Med Res. 2021;49(6):3000605211010649. https://doi.org/10.1177/03000605211010649.
      Kim M, Kwon H, Hong SK, Han Y, Park H, Choi JY, et al. Surgical treatment of central venous catheter related septic deep venous thrombosis. Eur J Vasc Endovasc Surg. 2015;49(6):670–675. https://doi.org/10.1016/j.ejvs.2015.01.023.
      Schranz D, Haugwitz D, Zimmer B, Schumacher R. Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue‐plasminogen activator. Klin Padiatr. 1991;203(5):363–365. Erfolgreiche Lysebehandlung einer septischen Thrombose der Vena cava superior mit rekombinantem Gewebe‐Plasminogen‐Aktivator. https://doi.org/10.1055/s-2007-1025454.
      Volkow P, Cornejo‐Juarez P, Arizpe‐Bravo AB, Garcia‐Mendez J, Baltazares‐Lipp E, Perez‐Padilla R. Catheter‐related septic thrombophlebitis of the great central veins successfully treated with low‐dose streptokinase thrombolysis and antimicrobials. Thromb J. 2005;3:11. https://doi.org/10.1186/1477-9560-3-11.
    • Contributed Indexing:
      Keywords: MRSA; postpartum; recanalization; right ovarian venous thrombosis; septic pelvic thrombophlebitis; tissue‐plasminogen activator
    • Accession Number:
      EC 3.4.21.68 (Tissue Plasminogen Activator)
      0 (Fibrinolytic Agents)
    • Publication Date:
      Date Created: 20240529 Date Completed: 20240801 Latest Revision: 20240801
    • Publication Date:
      20240802
    • Accession Number:
      10.1111/jog.15991
    • Accession Number:
      38807344